Medline INC Schedule 13G passive stakes

Several Hellman & Friedman affiliated entities have amended their Schedule 13G filing to report an aggregate beneficial ownership of 16.0% of Medline Inc.'s Class A common stock as of June 30, 2026.

Several Blackstone-affiliated entities have collectively reported beneficial ownership of approximately 16.5% of Medline Inc.'s Class A Common Stock as of June 30, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.5% of Medline Inc.'s Class A Common Stock as of June 30, 2026.

The Carlyle Group and its affiliates have filed a Schedule 13G reporting a 20.6% beneficial ownership stake in Medline Inc. Class A Common Stock.

Abu Dhabi Investment Authority and its subsidiary Platinum Falcon B 2018 RSC Limited have filed a Schedule 13G, reporting beneficial ownership of Medline Inc. Class A Common Stock.

Private equity firm Hellman & Friedman reports a significant 19.8% beneficial ownership in Medline Inc. following its recent initial public offering.

Blackstone and its affiliates have filed a Schedule 13G reporting beneficial ownership of 20.6% of Medline Inc. Class A common stock.

Hellman & Friedman entities have reported a significant 23.2% beneficial ownership in Medline Inc.'s Class A common stock.

Carlyle Group Inc. and its affiliates have reported a beneficial ownership of 24.4% of Medline Inc.'s Class A Common Stock as of December 31, 2025.

Abu Dhabi Investment Authority and its subsidiary Platinum Falcon B 2018 RSC Limited have disclosed a combined 5.9% beneficial ownership in Medline Inc.'s Class A Common Stock.